CompareMarketResearchRequest a sample
Home / Healthcare / Comparator Sourcing

Healthcare · Market report

Comparator Sourcing Market Size, Share and Forecast 2026-2036

The global comparator sourcing market is worth USD 976 mn in 2026 and is forecast to reach USD 2.2 bn by 2036, growing at a 8.5% CAGR. United States is the largest country market and Oncology is the largest by therapeutic area segment.

USD 976 mnMarket size 2026
USD 2.2 bnForecast 2036
8.5%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global comparator sourcing market is worth USD 976 mn in 2026 and is forecast to reach USD 2.2 bn by 2036, growing at a 8.5% CAGR. United States is the largest country market and Oncology is the largest by therapeutic area segment.

ScopeSourcing of marketed reference medicines used as comparators in clinical trials, with purchase, relabelling, certification and delivery to study sites, sold to drug developers.
IndustryHealthcare
Value 2025USD 900 mn
Value 2026USD 976 mn
Value 2036USD 2.2 bn
CAGR 2026-20368.5%
Volume 202631.9 thousand projects
Volume 203659.2 thousand projects
Average price 2026USD 30,600 per project
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Comparator Sourcing market size and forecast, 2026-2036

Exhibit 1The global comparator sourcing market is forecast to grow from USD 976 mn in 2026 to USD 2.2 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 8.5%
Comparator Sourcing market value, 2025 to 2036Market value by year. 2025: USD 900.0 mn; 2026: USD 976.5 mn; 2027: USD 1.06 bn; 2028: USD 1.15 bn; 2029: USD 1.25 bn; 2030: USD 1.35 bn; 2031: USD 1.47 bn; 2032: USD 1.59 bn; 2033: USD 1.73 bn; 2034: USD 1.88 bn; 2035: USD 2.03 bn; 2036: USD 2.21 bn. Compound annual growth rate 2026 to 2036: 8.5%.2025976.5 mn20261.47 bn20312.21 bn20368.5% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 976.5 mn
2027USD 1.06 bn
2028USD 1.15 bn
2029USD 1.25 bn
2030USD 1.35 bn
2031USD 1.47 bn
2032USD 1.59 bn
2033USD 1.73 bn
2034USD 1.88 bn
2035USD 2.03 bn
2036USD 2.21 bn

Comparator Sourcing market segmentation

By therapeutic area

Exhibit 2Oncology is the largest segment by therapeutic area, with 34.0% of 2026 revenueEstimated share of 2026 global revenue, by therapeutic area
Comparator Sourcing market share by therapeutic area, 2026Share of 2026 revenue by therapeutic area. Oncology: 34.0%; Immunology: 18.0%; Cardiovascular and metabolic: 18.0%; Others: 16.0%; Neurology: 14.0%.Oncology34.0%Immunology18.0%Cardiovascular and metabolic18.0%Others16.0%Neurology14.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Oncology34.0%38.5%USD 332 mn9.8%
Immunology18.0%18.6%USD 176 mn8.8%
Cardiovascular and metabolic18.0%15.4%USD 176 mn6.8%
Neurology14.0%13.8%USD 137 mn8.3%
Others16.0%13.7%USD 156 mn6.8%

By phase

Exhibit 3Phase III adds the most revenue by phase, growing from USD 586 mn in 2026 to USD 1.3 bn by 2036Estimated revenue in USD by phase, 2026 and 2036 forecast
Comparator Sourcing market by phase, 2026 and 2036Revenue by phase in 2026 and 2036. Phase III: USD 586 mn in 2026, USD 1.3 bn in 2036, change +128%; Phase II: USD 234 mn in 2026, USD 534 mn in 2036, change +128%; Phase IV: USD 156 mn in 2026, USD 340 mn in 2036, change +117%.20262036 forecastChangePhase III+128%586 mn1.3 bnPhase II+128%234 mn534 mnPhase IV+117%156 mn340 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Phase II24.0%24.2%USD 234 mn8.6%
Phase III60.0%60.4%USD 586 mn8.6%
Phase IV16.0%15.4%USD 156 mn8.1%

By source region

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
United States sourced38.0%36.0%USD 371 mn7.9%
European sourced34.0%33.0%USD 332 mn8.2%
Asia sourced16.0%18.0%USD 156 mn9.8%
Others regions12.0%13.0%USD 117 mn9.4%

By drug form

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Oral solids36.0%33.0%USD 352 mn7.6%
Injectables38.0%38.0%USD 371 mn8.5%
Biologics26.0%29.0%USD 254 mn9.7%

By client

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Large pharma48.0%44.0%USD 469 mn7.6%
Biotech30.0%34.0%USD 293 mn9.9%
CROs22.0%22.0%USD 215 mn8.5%

Top 25 countries for comparator sourcing by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 86.0% of 2026 revenue and the 25 countries below together hold 97.2%.

Exhibit 4United States is the largest country market at USD 371 mn in 2026, and the three largest countries hold 54.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Comparator Sourcing market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 371 mn, 38.0%; Germany: USD 78 mn, 8.0%; United Kingdom: USD 78 mn, 8.0%; China: USD 78 mn, 8.0%; France: USD 49 mn, 5.0%; Japan: USD 49 mn, 5.0%; Canada: USD 39 mn, 4.0%; Switzerland: USD 39 mn, 4.0%; Spain: USD 29 mn, 3.0%; Italy: USD 29 mn, 3.0%.United States371 mn 38.0%Germany78 mn 8.0%United Kingdom78 mn 8.0%China78 mn 8.0%France49 mn 5.0%Japan49 mn 5.0%Canada39 mn 4.0%Switzerland39 mn 4.0%Spain29 mn 3.0%Italy29 mn 3.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 371 mn38.0%USD 799 mn8.0%
2GermanyUSD 78 mn8.0%USD 177 mn8.5%
3United KingdomUSD 78 mn8.0%USD 177 mn8.5%
4ChinaUSD 78 mn8.0%USD 243 mn12.0%
5FranceUSD 49 mn5.0%USD 106 mn8.1%
6JapanUSD 49 mn5.0%USD 102 mn7.6%
7CanadaUSD 39 mn4.0%USD 84 mn7.9%
8SwitzerlandUSD 39 mn4.0%USD 84 mn7.9%
9SpainUSD 29 mn3.0%USD 66 mn8.5%
10ItalyUSD 29 mn3.0%USD 64 mn8.1%
11NetherlandsUSD 16 mn1.6%USD 34 mn8.1%
12BelgiumUSD 14 mn1.4%USD 30 mn8.1%
13IndiaUSD 14 mn1.4%USD 33 mn9.4%
14AustraliaUSD 11 mn1.1%USD 24 mn8.1%
15SwedenUSD 8.8 mn0.9%USD 19 mn8.1%
16DenmarkUSD 8.6 mn0.9%USD 19 mn8.1%
17South KoreaUSD 6.9 mn0.7%USD 17 mn9.4%
18BrazilUSD 5.6 mn0.6%USD 14 mn9.4%
19IsraelUSD 5.5 mn0.6%USD 12 mn8.1%
20MexicoUSD 4.4 mn0.5%USD 11 mn9.4%
21PolandUSD 4.1 mn0.4%USD 10 mn9.5%
22AustriaUSD 3.3 mn0.3%USD 7.1 mn7.8%
23SingaporeUSD 3.0 mn0.3%USD 7.5 mn9.5%
24TurkeyUSD 2.8 mn0.3%USD 6.8 mn9.2%
25Saudi ArabiaUSD 2.0 mn0.2%USD 5.1 mn9.5%
Rest of worldUSD 28 mn2.8%USD 57 mn7.6%
Exhibit 5United States and China account for 48% of the USD 1.2 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Comparator Sourcing market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 976 mn. United States: +USD 428 mn; China: +USD 165 mn; Germany: +USD 99 mn; United Kingdom: +USD 99 mn; France: +USD 57 mn; 20 other countries: +USD 355 mn; Rest of world: +USD 30 mn. Market value 2036: USD 2.2 bn.Market value 2026976 mnUnited States+428 mnChina+165 mnGermany+99 mnUnited Kingdom+99 mnFrance+57 mn20 other countries+355 mnRest of world+30 mnMarket value 20362.2 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Clinigen
  • Thermo Fisher Scientific
  • Almac Group

Group 2: Regional and specialist players

  • Myonex
  • Tanner Pharma Group
  • Ancillare
  • Mawdsleys Clinical Supplies
  • Catalent
  • PCI Pharma Services
  • Sharp Services
  • KLIFO

Group 3: Emerging and niche players

  • Yourway
  • Bionical Emas
  • Bilcare Global Clinical Supplies

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the comparator sourcing market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 8.5% is calculated from the resulting values.

The market is divided by therapeutic area, by phase, by source region, by drug form, by client. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the comparator sourcing market?

The global comparator sourcing market is estimated at USD 900 mn in 2025 and USD 976 mn in 2026.

How fast will the comparator sourcing market grow?

It is forecast to reach USD 2.2 bn by 2036, a compound annual growth rate of 8.5% from 2026, an increase of USD 1.2 bn.

Which country is the largest market for comparator sourcing?

United States is the largest market by revenue at USD 371 mn in 2026, 38.0% of the global total. The three largest countries together hold 54.0%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 12.0% a year from 2026 to 2036.

Which comparator sourcing segment is largest?

In the by therapeutic area split, Oncology is the largest segment with 34.0% of 2026 revenue.

Who are the leading comparator sourcing companies?

Global leaders include Clinigen, Thermo Fisher Scientific, Almac Group.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Companion Diagnostics Continuous Flow Bioreactors →

All Healthcare markets →

Request a sample